Dr. Axel Baur Senior Partner and Leader of McKinsey's Healthcare Practice Hong Kong

Axel is a senior partner in the Hong Kong office, having served previously in Europe, Middle East and Japan. He is the leader of McKinsey's Healthcare Practice in Asia, serving Pharmaceutical & Medical Product companies as well as Health Systems and Insurance companies. 

China's biopharma industry is transforming. 

Axel will share with us some of the findings from the 2021 McKinsey report (which is going to be published later in November) and shed a light on where he sees opportunities and obstacles for a European life science company wanting to enter the Chinese market.

Axel serves the broader healthcare industry, focusing on public and private health insurance as well as hospital operations. He advises top management in pharmaceutical and medical product companies along their entire value chain. Lately he has been dealing with significant rise of HealthTech innovation and has been advising large incumbents on how to take advantage as well as protect existing business.

Recently, Axel has supported numerous Asian players in setting up global operating models; he helps large private insurance companies develop strategies to exploit the growing opportunities in Asia; and he guides large transformations to extract synergies either from acquisitions or reduce significant amounts of the client’s operating costs.

Axel is an expert in innovative care delivery models and is heavily involved in developing McKinsey’s thinking on how healthcare systems can tackle future challenges.